Contents

Current Drug Targets - CNS & Neurological Disorders, Volume 2 - Number 6

Therapeutic Implications for Immunophilin Ligands in the Treatment of Neurodegenerative Diseases

, 2(6): 349 - 356

Kevin Pong and Margaret M. Zaleska


DOI: 10.2174/1568007033482652




Exploring Genetic Influences on Cognition: Emerging Strategies for Target Validation and Treatment Optimization

, 2(6): 357 - 362

John A. Fossella, Sonia Bishop and B. J. Casey


DOI: 10.2174/1568007033482689




GABAergic Functions and Depression: From Classical Therapies to Herbal Medicine

, 2(6): 363 - 373

Justin W.C. Leung and Hong Xue


DOI: 10.2174/1568007033482715




Cdk5 in the Adult Non-Demented Brain

, 2(6): 375 - 381

Andre Fischer, Farahnaz Sananbenesi, Joachim Spiess and Jelena Radulovic


DOI: 10.2174/1568007033482706




Therapeutic Potential of 5-HT2C Receptor Antagonists in the Treatment of Anxiety Disorders

, 2(6): 383 - 387

Martyn D. Wood


DOI: 10.2174/1568007033482698




Cannabinoids and Memory; Animal Studies

, 2(6): 389 - 402

Claudio Castellano, Clelia Rossi-Arnaud, Vincenzo Cestari and Marco Costanzi


DOI: 10.2174/1568007033482670




Extracellular ATP and Neurodegeneration

, 2(6): 403 - 412

Cinzia Volonte, Susanna Amadio, Fabio Cavaliere, Nadia D'Ambrosi, Fabrizio Vacca and Giorgio Bernardi


DOI: 10.2174/1568007033482643




Stress and Angiotensin II: Novel Therapeutic Opportunities

, 2(6): 413 - 419

Ines Armando, Alicia Seltzer, Claudia Bregonzio and Juan M. Saavedra


DOI: 10.2174/1568007033482661




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science